Rice William G. — SEC Form 4 filings

SEC reporting owner CIK 1761487. 3 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-02-07 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aptose Biosciences Inc. (APTO)Chair, President & CEO, Director31 leg · 100,000 sh · $20,00015

Form 4 filings — Rice William G.

FiledFormIssuerReported transactionsSource
2026-07-014Aptose Biosciences Inc. (APTO)Disposition to issuer (D): 613,252 @ $1.72 · Disposition to issuer (D): 70,000 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 400,000 (derivative) @ $0 · Disposition to issuer (D): 600,000 (derivative) @ $0 · Disposition to issuer (D): 700,000 (derivative) @ $0 · +7 moreEDGAR
2024-11-264Aptose Biosciences Inc. (APTO)Purchase (P): 100,000 @ $0.20 · Purchase (P): 50,000 (derivative)EDGAR
2024-02-074Aptose Biosciences Inc. (APTO)Grant/award (A): 70,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1761487 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →